Your browser doesn't support javascript.
loading
Características clínicas y mortalidad de la insuficiencia cardiaca. Estudio INCAex / Clinical characteristics and mortality of heart failure. INCAex study
Fernández-Bergés, D; Consuegra-Sánchez, L; Félix-Redondo, F. J; Robles, N. R; Galán Montejano, M; Lozano-Mera, L.
Affiliation
  • Fernández-Bergés, D; Hospital Don Benito-Villanueva. Badajoz. España
  • Consuegra-Sánchez, L; Hospital General Universitario de Santa Lucía. Cartagena. España
  • Félix-Redondo, F. J; Centro de Salud Villanueva Norte. Villanueva de la Serena. España
  • Robles, N. R; Hospital Universitario Infanta Cristina. Badajoz. España
  • Galán Montejano, M; Hospital Don Benito-Villanueva. Badajoz. España
  • Lozano-Mera, L; Unidad de Investigación Don Benito-Villanueva. Villanueva de la Serena. España
Rev. clín. esp. (Ed. impr.) ; 213(1): 16-24, ene.-feb. 2013.
Article in Spanish | IBECS | ID: ibc-109828
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Antecedentes y objetivos. La insuficiencia cardiaca es la causante del mayor gasto sanitario en hospitalización y la tercera causa de mortalidad cardiovascular. Fue nuestro objetivo determinar la evolución de las características clínicas, y los factores relacionados con el pronóstico en pacientes ingresados por insuficiencia cardiaca en un área de salud de Extremadura durante 10 años. Pacientes y métodos. Estudio observacional, retrospectivo y unicéntrico en pacientes consecutivos ingresados por insuficiencia cardiaca descompensada en un Hospital General de la provincia de Badajoz en el período 2000/2009. Resultados. Se incluyeron 2.220 pacientes con una edad media de 76,3 (DE±10,1) años, 54% mujeres. Estratificados en 4 períodos de 30 meses, se observó un significativo incremento de los pacientes mayores de 75 años (55 al 71%; p<0,001) y al alta una mayor prescripción de bloqueadores beta (12 al 34%; p<0,001), estatinas (8 al 31%; p<0,001), y anticoagulantes orales (13 al 25%; p<0,001). La mortalidad intrahospitalaria disminuyó del 13 al 8% (p<0,01) y al año del 30 al 23% (p<0,01). Fueron predictores independientes de mortalidad al año la edad (HR=1,04 [IC del 95% 1,02-1,05]), la diabetes (HR=1,35 [IC del 95% 1,11-1,66]) y la insuficiencia renal (HR=1,49 [IC del 95% 1,18-1,87]). Conclusiones. La mortalidad ha disminuido significativamente en la década a pesar del incremento de la edad. La edad, la diabetes y la insuficiencia renal crónica resultaron predictores independientes de mortalidad al año. La anticoagulación resultó protectora(AU)
ABSTRACT
Background and objectives. Heart failure is responsible for a major part of hospital health expenditure and the third cause of cardiovascular death. To describe the evolution of clinical features, and factors related to prognosis of patients admitted due to decompensated heart failure in a region of Extremadura during a period 10 years. Patients and methods. Observational, retrospective and single centre study of consecutive patients admitted due to decompensated heart failure in a general hospital in the province of Badajoz, during the period 2000/2009. Results. A total of 2220 patients with mean age of 76.3 (SD±10.1), being 54% female were included in the study. Stratified into four periods (30 months each), a significant increase in patients over 75 years was observed (55 vs. 71%; P<.001), as well as an increase in the prescription of beta blockers at discharge (12 vs. 34%, P<.001), statins (8 vs. 31%; P<.001), and oral anticoagulants (13 vs. 25%; P<.001). Hospital mortality significantly decreased from 13 to 8% (P<.01), and from 30 to 23% (P<.01) at one year follow-up. Age (HR per year=1.04 [95% CI 1.02 to 1.05]), diabetes (HR=1.35 [95% CI 1.11 to 1.66]) and chronic renal failure (HR=1.49 [95% CI 1.18 to 1.87]) were identified as independent predictors of all-cause mortality at one year of follow-up. Conclusions. Total mortality in patients with decompensated heart failure has declined significantly over the last decade, despite the increasing age. Age, diabetes and chronic renal failure were independent predictors of total mortality at one year. Oral anticoagulation was a protective factor(AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Cardiovascular Disease / Other circulatory Diseases Database: IBECS Main subject: Prognosis / Cardiovascular Diseases / Heart Failure / Anticoagulants Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: Spanish Journal: Rev. clín. esp. (Ed. impr.) Year: 2013 Document type: Article Institution/Affiliation country: Centro de Salud Villanueva Norte/España / Hospital Don Benito-Villanueva/España / Hospital General Universitario de Santa Lucía/España / Hospital Universitario Infanta Cristina/España / Unidad de Investigación Don Benito-Villanueva/España
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Cardiovascular Disease / Other circulatory Diseases Database: IBECS Main subject: Prognosis / Cardiovascular Diseases / Heart Failure / Anticoagulants Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: Spanish Journal: Rev. clín. esp. (Ed. impr.) Year: 2013 Document type: Article Institution/Affiliation country: Centro de Salud Villanueva Norte/España / Hospital Don Benito-Villanueva/España / Hospital General Universitario de Santa Lucía/España / Hospital Universitario Infanta Cristina/España / Unidad de Investigación Don Benito-Villanueva/España
...